AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 127.06 Increased By ▲ 0.02 (0.02%)
BOP 6.64 Decreased By ▼ -0.03 (-0.45%)
CNERGY 4.54 Increased By ▲ 0.03 (0.67%)
DCL 8.58 Increased By ▲ 0.03 (0.35%)
DFML 41.70 Increased By ▲ 0.26 (0.63%)
DGKC 87.40 Increased By ▲ 0.55 (0.63%)
FCCL 32.59 Increased By ▲ 0.31 (0.96%)
FFBL 64.87 Increased By ▲ 0.07 (0.11%)
FFL 10.24 Decreased By ▼ -0.01 (-0.1%)
HUBC 109.23 Decreased By ▼ -0.34 (-0.31%)
HUMNL 14.65 Decreased By ▼ -0.03 (-0.2%)
KEL 5.11 Increased By ▲ 0.06 (1.19%)
KOSM 7.56 Increased By ▲ 0.10 (1.34%)
MLCF 41.65 Increased By ▲ 0.27 (0.65%)
NBP 59.61 Decreased By ▼ -0.80 (-1.32%)
OGDC 193.00 Increased By ▲ 2.90 (1.53%)
PAEL 28.17 Increased By ▲ 0.34 (1.22%)
PIBTL 7.83 No Change ▼ 0.00 (0%)
PPL 151.20 Increased By ▲ 1.14 (0.76%)
PRL 27.26 Increased By ▲ 0.38 (1.41%)
PTC 16.01 Decreased By ▼ -0.06 (-0.37%)
SEARL 86.02 Increased By ▲ 0.02 (0.02%)
TELE 7.75 Increased By ▲ 0.04 (0.52%)
TOMCL 35.55 Increased By ▲ 0.14 (0.4%)
TPLP 8.20 Increased By ▲ 0.08 (0.99%)
TREET 16.48 Increased By ▲ 0.07 (0.43%)
TRG 53.39 Increased By ▲ 0.10 (0.19%)
UNITY 26.25 Increased By ▲ 0.09 (0.34%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
BR100 9,998 Increased By 114.2 (1.15%)
BR30 31,214 Increased By 613.5 (2%)
KSE100 94,225 Increased By 869.6 (0.93%)
KSE30 29,197 Increased By 266.3 (0.92%)

Chinese medical tech platform WuXi AppTec raised $1.01 billion in its Hong Kong listing, sources said, valuing the company at $10.2 billion in a deal that marks one of this year's last big stock offerings in the Asian financial hub. Shanghai-listed WuXi AppTec priced its Hong Kong shares at HK$68 ($8.71) apiece, at the middle of an indicated range of HK$64.1-HK$71.5, the sources told Reuters on Friday. That represents a discount of 25 percent to its closing price of 79.99 yuan ($11.63) on Thursday.
It could raise up to $1.16 billion if an over-allotment option is exercised within a month of the start of trading, which would value the company at $10.3 billion, according to a term sheet seen by Reuters. WuXi AppTec shares will begin trading in Hong Kong on Dec. 13. WuXi AppTec did not respond to Reuters request for comment. This listing should serve as positive news for Hong Kong, where many firms such as Meituan Dianping have sunk below their initial public offering (IPO) prices, while others have scaled back their targeted fundraising amid jittery markets.
Bankers have been hoping for WuXi AppTec and tech giant Tencent's music arm, which launched its highly anticipated US IPO of up to $1.2 billion on Monday, to help usher in 2019 on a positive note. Referring to previous day's guidance of HK$70, a source said, WuXi AppTec could have priced higher, but wanted to leave money on the table because of volatile markets this week.
Hong Kong is poised to become the world's top IPO centre by volume this year, with $33.2 billion raised so far, Refinitiv data shows. However, concerns over mounting trade friction between China and the United States and slowing growth in the world's second-biggest economy continued to weigh. Hong Kong's benchmark Hang Seng index is down more than 12 percent this year. Shanghai-based WuXi AppTec describes itself as the largest pharmaceutical R&D services platform in Asia by revenue.

Copyright Reuters, 2018

Comments

Comments are closed.